[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350258-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350258-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","embryonic-stem-cell-factors-dppa24-amplify-active-h3k4me3-h2ak119ub-chromatin-domains-in-non-small-cell-lung-cancer","Embryonic stem cell factors DPPA2/4 amplify active H3K4me3 - H2AK119ub chromatin domains in non-small cell lung cancer","","Embryonic pluripotency priming factors DPPA2/4 are re-expressed in cancers, yet their molecular roles in tumor chromatin are unclear. In non-small cell lung cancer (NSCLC), DPPA2/4 coexpression associates with poorly differentiated tumors and worse outcomes. DPPA2/4 multimerize for stability and enhance nucleosome binding, targeting CG-rich developmental, Wnt, and catabolic gene promoters. Chromatin modeling and sequential ChIP show preferential binding to active H3K4me3 and H3K27ac domains enriched for PRC1 product H2AK119ub, maintained by RING1B, while H3K27me3 is absent. Forced expression promotes active chromatin and increases xenograft growth, supporting DPPA2/4 as molecular amplifiers of active and poised chromatin.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/embryonic-stem-cell-factors-dppa24-amplify-active-h3k4me3-h2ak119ub-chromatin-domains-in-non-small-cell-lung-cancer/350258/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/embryonic-stem-cell-factors-dppa24-amplify-active-h3k4me3-h2ak119ub-chromatin-domains-in-non-small-cell-lung-cancer/350258.png","ImageObject",300,407,{"name":42,"@type":43},"วิน","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How is DPPA2/4 expression linked to NSCLC outcomes?","Question",{"text":63,"@type":64},"DPPA2/4 coexpression in NSCLC correlates with poorly differentiated tumors and impaired patient outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What chromatin domains do DPPA2/4 preferentially bind?",{"text":68,"@type":64},"DPPA2/4 preferentially bind active H3K4me3 and H3K27ac domains enriched for PRC1 and its product H2AK119ub, confirmed by H3K4me3–H2AK119ub sequential ChIP.",{"name":70,"@type":61,"acceptedAnswer":71},"What happens when DPPA2/4 are knocked down or overexpressed in NSCLC cells?",{"text":72,"@type":64},"Knockdown shows DPPA2/4 are required to maintain RING1B and H2AK119ub at these domains. Overexpression drives binding to active chromatin, increases in vivo xenograft tumor growth, and uncouples PRC2 recruitment from H3K27me3 formation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350258,1790142134,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","Embryonic stem cell factors DPPA2/4 amplify active H3K4me3–H2AK119ub chromatin domains in non-small cell lung cancer  \nJanith A. Seneviratne, 1,2 Clare L. Crisp,1 Eleanor Glancy,1,2 Natalie Choy,1,2 Winnie Tan,3,4,5 Matthew Neve,1,2 Melanie Stammers,6 Tongtong Wang,1,2 Ruby Johnstone,1 Arshnoor Kaur,1 Katie A. Fennell,1,2 Marian L. Burr,7,8 Benjamin L. Parker,9 Shabih Shakeel,3,4,5,10 and Melanie A. Eckersley-Maslin 1,2,9  \n1Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia; 2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria 3000, Australia; 3Walter and Eliza Hall Institute, Parkville, Victoria 3052, Australia; 4Department of Medical Biology, The University of Melbourne, Melbourne, Victoria 3052, Australia; 5Australian Research Council, Centre for Cryo-Electron Microscopy of Membrane Proteins, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3052, Australia; 6Babraham Institute, Babraham, Cambridge CB22 3AT, United Kingdom; 7The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory 2601, Australia; 8Department of Anatomical Pathology, ACT Pathology, Canberra Health Services, Canberra, Australian Capital Territory 2605, Australia; 9Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Victoria 3010, Australia; 10Department of Biochemistry and Pharmacology, The University of Melbourne, Melbourne, Victoria 3052, Australia  \nEmbryonic regulators are often re-expressed in cancers; however, the functional and molecular significance of this isnot always understood. The epigenetic priming factors developmental pluripotency-associated2 and 4 (DPPA2/4) have crucial roles in early development and are implicated in cancer pathogenesis. We reveal that in non-small cell lung cancer (NSCLC), DPPA2/4 coexpression is associated with poorly differentiated tumors and impaired patient outcomes. Biochemically, human DPPA2/4 multimerize for their protein stability and enhanced nucleosome binding activity. In NSCLC cells, DPPA2/4 bind CG-rich sequences including promoters of developmental genes, Wnt signaling, and catabolic genes. Chromatin state modeling revealed that DPPA2/4 preferentially bind active H3K4me3 and H3K27ac domains that were intriguingly also enriched for PRC1 and its product, H2AK119ub, which was validated by H3K4me3–H2AK119ub sequential ChIP. Knockdown experiments revealed that DPPA2/4 were required to maintain RING1B and H2AK119ub at these domains. Surprisingly, despite the presence of PRC2.1, these regions lacked any detectable H3K27me3, suggesting an uncoupling between the recruitment of PRC2 to chromatin and its catalytic product. When exogenously overexpressed inNSCLC cells where they are not normally present, DPPA2/4 bind to and promote active chromatin states, resulting in an increase in in vivo xenograft tumor growth. Our results demonstrate how, in NSCLC cells, DPPA2/4 act as molecular amplifiers of active and poised chromatin. Together, this highlightshow aberrant reactivation of embryonic factors in cancers may take on new functions, promoting tumorigenesis.  \n[Keywords: DPPA2/4; H2AK119ub; NSCLC; chromatin; polycomb; priming factors] Supplemental material is available for this article.  \nReceived June 17, 2025; revised version accepted December 8, 2025 .  \nCancers often undergo dedifferentiation and upregulate transcription and chromatin regulators associated with stem cells and embryonic states. This has been linked with increased plasticity and aggressiveness and, ultimately, impaired survival outcomes (Hölzel et al. 2013;  \nFriedmann-Morvinski and Verma 2014; Aiello and Stanger 2016; Yuan et al. 2019; Boumahdi and de Sauvage 2020; Li and Stanger 2020; Hanahan 2022; Sharma et al. 2022) . While we often have a strong understanding of the molecular roles and functions of these embryonic factors in developmental and healthy contex","cbCaifwBiit6ib5C","https://ap.wps.com/l/cbCaifwBiit6ib5C","pdf",67105065,21,"English","# Key findings\n## Clinical association in NSCLC\n## Biochemical mechanism and chromatin targeting\n## PRC1-linked histone marks and loss of H3K27me3\n## Functional effects of knockdown and overexpression","[{\"question\":\"How is DPPA2/4 expression linked to NSCLC outcomes?\",\"answer\":\"DPPA2/4 coexpression in NSCLC correlates with poorly differentiated tumors and impaired patient outcomes.\"},{\"question\":\"What chromatin domains do DPPA2/4 preferentially bind?\",\"answer\":\"DPPA2/4 preferentially bind active H3K4me3 and H3K27ac domains enriched for PRC1 and its product H2AK119ub, confirmed by H3K4me3–H2AK119ub sequential ChIP.\"},{\"question\":\"What happens when DPPA2/4 are knocked down or overexpressed in NSCLC cells?\",\"answer\":\"Knockdown shows DPPA2/4 are required to maintain RING1B and H2AK119ub at these domains. Overexpression drives binding to active chromatin, increases in vivo xenograft tumor growth, and uncouples PRC2 recruitment from H3K27me3 formation.\"}]","Embryonic stem cell factors DPPA2/4 amplify active H3K4me3 - H2AK119ub chromatin domains in non-small cell lung cancer | PDF",1790088109,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/869cefbf39e70c58d721f5d12cedeaaf.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a892140fba74bb52f27718d648e4348c.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ee81db705bd7c09ae4680642b252668.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08383a86441f076ef15be0bfb2fd129e.webp",980,1268]